MISOPROSTOL: ULCER PROPHYLAXIS AT WHAT COST?
- 3 December 1988
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 332 (8623) , 1293-1294
- https://doi.org/10.1016/s0140-6736(88)92900-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ, 1988
- Alcohol consumption and the workplace: Prospects for change?Public Health, 1988
- Frequency of Neurosurgical Disorders in the U.K.British Journal Of Neurosurgery, 1988
- PROSTAGLANDINS FOR PEPTIC ULCER: A PROMISE UNFULFILLEDThe Lancet, 1986
- PEPTIC ULCER COMPLICATIONS AND THE USE OF NON-ASPIRIN NON-STEROIDAL ANTI-INFLAMMATORY DRUGSAdverse Drug Reaction Bulletin, 1986
- RISING FREQUENCY OF ULCER PERFORATION IN ELDERLY PEOPLE IN THE UNITED KINGDOMThe Lancet, 1986
- Overview of misoprostol clinical experienceDigestive Diseases and Sciences, 1986
- Overview of clinical safety with misoprostolDigestive Diseases and Sciences, 1985
- From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugsThe American Journal of Medicine, 1983
- Diagnosis of Acoustic NeuromaNeurosurgery, 1981